Belite Bio, Inc American Depositary Shares (BLTE) is a publicly traded Healthcare sector company. As of May 20, 2026, BLTE trades at $144.22 with a market cap of $5.71B and a P/E ratio of 0.00. BLTE moved +4.95% today. Year to date, BLTE is -12.29%; over the trailing twelve months it is +114.92%. Its 52-week range spans $43.70 to $200.00. Analyst consensus is strong buy with an average price target of $215.29. Rallies surfaces BLTE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for BLTE, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $144.22 |
| Market Cap | $5.71B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $200.00 |
| 52-Week Low | $43.70 |
| Volume | 150.82K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
7 analysts cover BLTE: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $215.29.